SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lincoln Pharmaceuticals informs about updates

09 May 2025 Evaluate
Lincoln Pharmaceuticals has informed that the Company does not fall under the category of Large Corporates (LC) as on 31st March 2025, as per the framework provided in the said Circular since the specified criteria are not applicable to the company. The undertaking as required under the said circular is enclosed as (Annexure -A).

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

644.30 -1.10 (-0.17%)
04-May-2026 11:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1821.80
Dr. Reddys Lab 1303.60
Cipla 1326.10
Zydus Lifesciences 900.90
Lupin 2347.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×